The article that dinged AstraZeneca was a Bloomberg piece asserting that the company is in discussions with Summit Therapeutics (SMMT -5.18%) on a formal partnership. Image source: Getty Images.

AstraZeneca chief executive officer Pascal Soriot would like to move the drugmaker's stock market listing to the U.S.

SAN FRANCISCO — Patients with bronchiectasis and a Pseudomonas aeruginosa infection receiving gremubamab, a bispecific monoclonal antibody, vs. placebo had several improved outcomes ...

This study aims to understand how food and a P-gp inhibitor affect the absorption and processing of these drugs, which could inform future dosing recommendations and enhance therapeutic efficacy.

This study could significantly impact AstraZeneca’s market position by potentially validating a more effective treatment regimen for T2DM, which may enhance investor confidence.

FDA grants accelerated approval to AstraZeneca's Datroway for EGFR-mutant NSCLC after prior therapies, with a 45% response rate and a $45 million milestone due.

Photo: rachel wisniewski/Reuters AstraZeneca and Daiichi Sankyo’s Datroway drug has been approved in the U.S. to treat adult patients with non-small cell lung cancer.

Find out about the University of Edinburgh's work to convert our common plastic wast into the wildly used paracetamol.

Climate Solutions Plastic bag fees and bans help protect beaches and riverbanks, study finds But even places with bag policies are seeing a greater prevalence of plastic bags on beaches and ...

In their study published in the journal Nature Machine Intelligence, Sheffield computer scientists in collaboration with AstraZeneca and the University of Southampton have developed a new machine ...

An AI approach developed by researchers from the University of Sheffield and AstraZeneca, could make it easier to design proteins needed for new treatments. In a study published in the journal ...

The study was a result of a non-funded collaboration of combined industry expertise, and builds on previous work between the Sheffield computer scientists and AstraZeneca, which developed DrugBAN – AI ...